Avion Wealth’s Ionis Pharmaceuticals IONS Stock Holding History

Avion Wealth’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6	Closed	–	–	1421
2025 Q4	$0	Buy	+6	New	+$452	﹤0.01%	1410
2025 Q2	–	Sell	-54	Closed	-$1K	–	1384
2025 Q1	$1K	Hold	54	–	–	﹤0.01%	867
2024 Q4	$1K	Buy	+54	New	+$2.02K	﹤0.01%	864
2024 Q1	–	Sell	-25	Closed	-$1K	–	1185
2023 Q4	$1K	Buy	+25	New	+$1.2K	﹤0.01%	834

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Avion Wealth's IONS Position: Q1 2026 in Review

Avion Wealth sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 6 shares.

Avion Wealth first reported a position in IONS in Q4 2023 and held it in 4 quarters. The position peaked at $1K in Q1 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

Avion Wealth reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Avion Wealth sold 6 Ionis Pharmaceuticals shares in Q1 2026.
Avion Wealth first reported a position in Ionis Pharmaceuticals in Q4 2023 and held it in 4 quarters.
Avion Wealth's Ionis Pharmaceuticals position peaked at $1K in Q1 2025.
493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Avion Wealth's 13F filing for Q1 2026, filed 1 May 2026.